Pharmacokinetics of Cotadutide in Participants With Hepatic Impairment
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
- Status
- RECRUITING
- Phase
- PHASE2
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
- Status
- RECRUITING
- Phase
- PHASE2
Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2
Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2
- Status
- WITHDRAWN
- Phase
- PHASE2
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI With Next-Generation Propellant Compared With BGF MDI With HFA Propellant
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL
- Status
- WITHDRAWN
- Phase
- PHASE2
Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)
- Status
- COMPLETED
- Phase
- N/A